$-0.16 EPS Expected for Check Cap Ltd (CHEK)

November 5, 2017 – By Marie Mckinney

Investors wait Check Cap Ltd (NASDAQ:CHEK) to report on November, 15. its quarterly earnings Wall Street analysts expect $-0.16 earnings per share, down $0.05 or 45.45 % from last year’s $-0.11 same quarter earnings. Check Cap Ltd’s Wall Street analysts see -5.88 % EPS growth, taking into account the $-0.17 EPS reproted in the previous quarter, The stock increased 5.43% or $0.07 on November 3, reaching $1.36. About 28,058 shares traded. Check Cap Ltd (NASDAQ:CHEK) has declined 2.26% since November 5, 2016 and is downtrending. It has underperformed by 18.96% the S&P500.

Check Cap Ltd (NASDAQ:CHEK) Ratings Coverage

Among 4 analysts covering Check-Cap (NASDAQ:CHEK), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Check-Cap had 9 analyst reports since July 22, 2015 according to SRatingsIntel. Chardan Capital Markets maintained the stock with “Buy” rating in Wednesday, March 16 report. The stock has “Buy” rating by Maxim Group on Tuesday, May 30. The stock has “Buy” rating by Maxim Group on Thursday, October 8. The rating was initiated by Rodman & Renshaw on Thursday, January 19 with “Buy”. Chardan Capital Markets maintained the stock with “Buy” rating in Friday, May 20 report. The rating was maintained by Maxim Group on Tuesday, January 19 with “Buy”. On Wednesday, July 22 the stock rating was maintained by Chardan Capital Markets with “Buy”. H.C. Wainwright maintained the shares of CHEK in report on Thursday, September 28 with “Buy” rating. The stock of Check Cap Ltd (NASDAQ:CHEK) earned “Buy” rating by H.C. Wainwright on Friday, August 11.

Check-Cap Ltd. is a clinical-stage medical diagnostics company. The company has market cap of $23.09 million. The Firm is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. It currently has negative earnings. The Company’s system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient’s back, and a personal computer (PC) work station for data reconstruction and image processing.

More important recent Check Cap Ltd (NASDAQ:CHEK) news were published by: Prnewswire.com which released: “Check-Cap Announces Acceptance of Late Breaking Clinical Performance Abstract …” on October 24, 2017, also Prnewswire.com published article titled: “Check-Cap Ltd. Announces Closing of $2.69 Million Financing”, Prnewswire.com published: “Check-Cap Announces Filing of CE Mark Registration for C-Scan®” on September 27, 2017. More interesting news about Check Cap Ltd (NASDAQ:CHEK) was released by: Prnewswire.com and their article: “Check-Cap Ltd. Announces $2.69 Million Financing” with publication date: May 30, 2017.